Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30444123 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL8909475 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL15539874 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL20537468 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL15540195 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL29418871 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL2353735 | 0.82 | ALDH1A1 (0.74) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL38657948 | 0.82 | ALDH1A1 (0.74) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL2634390 | 0.82 | ALDH1A1 (0.74) | ALDH1A1CYP1A2NPSR1MAPTTSHR | |
| SCHEMBL12788041 | 0.80 | ALDH1A1 (1.00) | ALDH1A1CYP1A2NPSR1MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7872146-B2 | Process for the preparation of a carboxamide derivative | BAYER CROPSCIENCE AG (DE) | 2011-01-18 | — | — | US | disclosed |
| EP-1881963-B1 | PROCESS FOR THE PREPARATION OF A CARBOXAMIDE DERIVATIVE | BAYER CROPSCIENCE AG (DE) | 2010-07-14 | — | — | EP | disclosed |
| US-20090062552-A1 | PROCESS FOR THE PREPARATION OF A CARBOXAMIDE DERIVATIVE | BAYER CROPSCIENCE AG (DE) | 2009-03-05 | — | — | US | disclosed |
| EP-1881963-A1 | PROCESS FOR THE PREPARATION OF A CARBOXAMIDE DERIVATIVE | Bayer CropScience S.A. (FR) | 2008-01-30 | — | — | EP | disclosed |
| WO-2006120031-A1 | PROCESS FOR THE PREPARATION OF A CARBOXAMIDE DERIVATIVE | BAYER CROPSCIENCE S.A. (FR) | 2006-11-16 | — | — | WO | disclosed |
| EP-1721899-A1 | Process for the preparation of a carboxamide derivative | Bayer CropScience S.A. (FR) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062552-A1 | PROCESS FOR THE PREPARATION OF A CARBOXAMIDE DERIVATIVE | CPS1, SDHA, CS | ALDH1A1 284/4885CYP1A2 66/4885NPSR1 1789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.